DEFINE-PCI Study: 60 Second Insights

Published: 20 March 2019

  • Views:

    Views Icon 1959
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

A series of 60-second interviews where Justin Davies, Allen Jeremias, Takashi Akasaka and Bruce Samuels provide their thoughts on the DEFINE-FLAIR Study.

More from this programme

Part 1

How has Define-FLAIR affected your clinical practice?

Part 2

In what kind of scenarios would residual ischaemia be addressable or not?

Part 3

How does residual ischaemia impact the healthcare system?

Part 4

What has been your experience with tools like iFR co-registration?

Part 5

What's next in the research pipeline?

Part 6

How will it change your clinical practice?

Part 7

What were the key findings from DEFINE-PCI?

Part 8

Do you think the broader interventional community believes post-PCI ischaemia is a real problem?

Part 9

How is DEFINE PCI different from earlier post-PCI ischaemia studies?

Part 10

Why was DEFINE PCI done, is there precedent for post-PCI ischaemia?

Part 11

What would be surprising to see from DEFINE PCI?

Part 12

What do we hope DEFINE PCI will shed light on?

Faculty Biographies

Allen Jeremias

Allen Jeremias

Director of Interventional Cardiology Research and Associate Director, Cardiac Catheterization

Dr Allen Jeremias, MD, MSc is an interventional cardiologist at St. Francis Hospital, Roslyn, NY and Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory. He is also the Director of the Physiology Core Laboratory at the Cardiovascular Research Foundation, New York, NY.

Dr Jeremias earned his medical degree at Heinrich-Heine-University School of Medicine in Düsseldorf, Germany, and a Master of Science degree at Harvard Medical School. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, as well as Beth Israel Deaconess Medical Center, Harvard Medical School.

View full profile